Molins Technologies is pleased to announce the completion of its new ISO 7 (class 10,000) containment room. These new facilities will enable us to continue to support our customers with dosing trials, technology proving exercises and first-of-a-kind systems where the use of active pharmaceutical ingredients (API’s) and hazardous substances are required. Molins Technologies’ Pharmaceutical Solutions including the µ-fill suite of powder dosing technologies will also be located within the new facilities.
Jonathan Firnberg, Sales Director at Molins Technologies commented, “Our containment facility offers the ability to process and test active pharmaceutical formulations in a safe, contained and controlled environment. Customers benefit from our product handling expertise and our ability to define and apply the most appropriate technology for the specific individual client requirements.”
Find out more about our new containment room and the facilities at Molins Technologies here.